Chemours stock reaction draws attention
Chemours (CC) has drawn fresh interest after recent trading, with the stock closing at US$21.52 and showing mixed short and longer term returns that invite a closer look at valuation and fundamentals.
See our latest analysis for Chemours.
Recent trading has been choppy, with a strong 1-day share price return of 5.96% standing against a 30-day share price return that is down 12.77%. The year to date share price return of 75.67% and 1-year total shareholder return of 91.71% point to earlier momentum that has cooled relative to recent weeks.
If Chemours’s recent swings have you thinking about portfolio balance, it could be a good moment to see what other materials related opportunities look like using the 8 top copper producer stocks.
With Chemours trading at US$21.52 and screening on some metrics at a discount to both analyst targets and intrinsic value estimates, you need to ask: is there still a buying opportunity here, or is the market already pricing in future growth?
Most Popular Narrative: 18.3% Undervalued
Compared with the last close at $21.52, the most followed narrative points to a fair value of $26.33, framing Chemours as meaningfully undervalued on that view.
Acceleration in regulatory-driven adoption of low global warming potential refrigerants is boosting sustained demand for Chemours' Opteon franchise. Recent strong net sales and high margins signal that continued market share gains and capacity expansions will drive robust revenue and EBITDA growth through and beyond the 2025 and 2026 transition periods.
The fair value call leans heavily on higher earnings quality, wider margins, and a re rated profit base anchored to future refrigerant and advanced materials demand. Want to see exactly how revenue, margin, and earnings assumptions stack up in that model, and which profit multiple underpins the $26.33 figure?
Result: Fair Value of $26.33 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on PFAS litigation and regulatory pressure not escalating in ways that drain cash, or TiO2 competition and pricing undercutting the margin recovery story.
Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.
Next Steps
Mixed signals on value and risk so far? If you want to move quickly and build your own view from the ground up, start with the 4 key rewards and 2 important warning signs.
Looking for more investment ideas?
If this update has sharpened your focus, do not stop here. The next strong addition to your portfolio could be sitting in plain sight.
- Spot potential high yield anchors for your portfolio by scanning companies in the 8 dividend fortresses and see which income ideas stand out today.
- Hunt for quality at a discount by checking the 46 high quality undervalued stocks and compare how these candidates stack up on fundamentals.
- Prioritize resilience by reviewing companies in the 67 resilient stocks with low risk scores and see which businesses line up with your comfort level.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com